Literature DB >> 29273150

Research Techniques Made Simple: Murine Models of Human Psoriasis.

Jason E Hawkes1, Jonas A Adalsteinsson2, Johann E Gudjonsson3, Nicole L Ward4.   

Abstract

Psoriasis vulgaris is a common, inflammatory skin disease affecting approximately 3% of the population in the United States. The etiology of psoriasis and its associated comorbidities are complex and the result of complicated interactions between the skin, immune system, disease-associated susceptibility loci, and multiple environmental triggers. The modeling of human disease in vivo through the use of murine models represents a powerful, indispensable tool for investigating the immune and genetic mechanisms contributing to a clinical disease phenotype. Nevertheless, modeling a complex, multigenic disease like psoriasis in mice has proven to be extremely challenging and is associated with significant limitations. Over the last four decades, more than 40 unique mouse models for psoriasis have been described. These models can be categorized into three major types: acute (inducible), genetically engineered (transgenic), and xenograft (humanized). The purpose of this Research Techniques Made Simple article is to provide an overview of the common types of psoriasis-like mouse models currently in use and their inherent advantages and limitations. We also highlight the need for improved psoriasis mouse model systems and several key factors to be considered as this field of laboratory science advances.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29273150      PMCID: PMC6902858          DOI: 10.1016/j.jid.2017.10.013

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  32 in total

1.  Transgenic mouse technology in skin biology: inducible gene knockout in mice.

Authors:  Christian Günschmann; Elena Chiticariu; Bhavuk Garg; Merve Meliha Hiz; Yora Mostmans; Maria Wehner; Lukas Scharfenberger
Journal:  J Invest Dermatol       Date:  2014-07       Impact factor: 8.551

2.  Extended DNFB-induced contact hypersensitivity models display characteristics of chronic inflammatory dermatoses.

Authors:  Lars Röse; Claudia Schneider; Christine Stock; Thomas M Zollner; Wolf-Dietrich Döcke
Journal:  Exp Dermatol       Date:  2012-01       Impact factor: 3.960

3.  Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype.

Authors:  P W Cook; M Piepkorn; C H Clegg; G D Plowman; J M DeMay; J R Brown; M R Pittelkow
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

4.  Innate immune response in Th1- and Th2-dominant mouse strains.

Authors:  Hiroyuki Watanabe; Kousuke Numata; Takaaki Ito; Katsumasa Takagi; Akihiro Matsukawa
Journal:  Shock       Date:  2004-11       Impact factor: 3.454

5.  IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation.

Authors:  Hak-Ling Ma; Spencer Liang; Jing Li; Lee Napierata; Tom Brown; Stephen Benoit; Mayra Senices; Davinder Gill; Kyriaki Dunussi-Joannopoulos; Mary Collins; Cheryl Nickerson-Nutter; Lynette A Fouser; Deborah A Young
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

Review 6.  Of mice and not men: differences between mouse and human immunology.

Authors:  Javier Mestas; Christopher C W Hughes
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

7.  Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.

Authors:  Andrew Johnston; Yi Fritz; Sean M Dawes; Doina Diaconu; Paul M Al-Attar; Andrew M Guzman; Cynthia S Chen; Wen Fu; Johann E Gudjonsson; Thomas S McCormick; Nicole L Ward
Journal:  J Immunol       Date:  2013-01-28       Impact factor: 5.422

8.  Keratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function.

Authors:  Sirish K Ippagunta; Ruchika Gangwar; David Finkelstein; Peter Vogel; Stephane Pelletier; Sebastien Gingras; Vanessa Redecke; Hans Häcker
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

9.  Aldara activates TLR7-independent immune defence.

Authors:  Anne Walter; Matthias Schäfer; Virginia Cecconi; Claudia Matter; Mirjana Urosevic-Maiwald; Benedetta Belloni; Nicola Schönewolf; Reinhard Dummer; Wilhelm Bloch; Sabine Werner; Hans-Dietmar Beer; Alexander Knuth; Maries van den Broek
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 10.  Psoriasis and comorbid diseases: Epidemiology.

Authors:  Junko Takeshita; Sungat Grewal; Sinéad M Langan; Nehal N Mehta; Alexis Ogdie; Abby S Van Voorhees; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2017-03       Impact factor: 11.527

View more
  10 in total

1.  Meeting Report: 68th Montagna Symposium on the Biology of Skin "Decoding Complex Skin Diseases: Integrating Genetics, Genomics, and Disease Biology".

Authors:  Johann E Gudjonsson; James T Elder
Journal:  J Invest Dermatol       Date:  2020-06-27       Impact factor: 8.551

Review 2.  Research Techniques Made Simple: Forward Genetic Screening to Uncover Genes Involved in Skin Biology.

Authors:  William McAlpine; Jamie Russell; Anne R Murray; Bruce Beutler; Emre Turer
Journal:  J Invest Dermatol       Date:  2019-09       Impact factor: 8.551

Review 3.  Psoriasis: Past, Present, and Future.

Authors:  Allison C Billi; Johann E Gudjonsson; John J Voorhees
Journal:  J Invest Dermatol       Date:  2019-11       Impact factor: 8.551

4.  Gain of function p.E138A alteration in Card14 leads to psoriasiform skin inflammation and implicates genetic modifiers in disease severity.

Authors:  John P Sundberg; C Herbert Pratt; Kathleen A Silva; Victoria E Kennedy; Wenning Qin; Timothy M Stearns; Jacqueline Frost; Beth A Sundberg; Anne M Bowcock
Journal:  Exp Mol Pathol       Date:  2019-07-16       Impact factor: 3.362

Review 5.  Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis.

Authors:  Jason E Hawkes; Bernice Y Yan; Tom C Chan; James G Krueger
Journal:  J Immunol       Date:  2018-09-15       Impact factor: 5.422

Review 6.  Inflammasomes in Common Immune-Related Skin Diseases.

Authors:  Lili Tang; Fusheng Zhou
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

7.  Interleukin-17 cytokines: Effectors and targets in psoriasis-A breakthrough in understanding and treatment.

Authors:  Immo Prinz; Inga Sandrock; Ulrich Mrowietz
Journal:  J Exp Med       Date:  2020-01-06       Impact factor: 14.307

8.  Polysaccharide mycophenolate-based nanoparticles for enhanced immunosuppression and treatment of immune-mediated inflammatory diseases.

Authors:  Yuce Li; Yuchen Lou; Yu Chen; Jing Yang; Danqi Li; Biling Jiang; Jiajia Lan; Jingjing Wen; Yangxue Fu; Yamin Zhang; Juan Tao; Jintao Zhu
Journal:  Theranostics       Date:  2021-01-26       Impact factor: 11.556

9.  Phosphodiesterase-4 Inhibition Reduces Cutaneous Inflammation and IL-1β Expression in a Psoriasiform Mouse Model but Does Not Inhibit Inflammasome Activation.

Authors:  Barbara Meier-Schiesser; Mark Mellett; Marigdalia K Ramirez-Fort; Julia-Tatjana Maul; Annika Klug; Nicola Winkelbeiner; Gabriele Fenini; Peter Schafer; Emmanuel Contassot; Lars E French
Journal:  Int J Mol Sci       Date:  2021-11-28       Impact factor: 5.923

10.  Molecular and histopathological profiling of imiquimod induced dermatosis in Swiss Wistar rats: contribution to the rat model for novel anti-psoriasis treatments.

Authors:  Ajla Smajlović; Anja Haverić; Amer Alić; Maida Hadžić; Ahmed Smajlović; Indira Mujezinović; Naida Lojo-Kadrić; Jasmin Ramić; Nikolina Elez-Burnjaković; Sanin Haverić; Lejla Pojskić
Journal:  Mol Biol Rep       Date:  2021-06-07       Impact factor: 2.316

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.